Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $3.50 Analyst target: $6.10 Upside: 74.29%
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.